Jubilant Pharmova Limited (JUBLPHARMA.NS)
INR 906.95
(1.0%)
INR 906.95
(1.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 67.02 Billion INR | 7.78% |
| 2022 | 62.19 Billion INR | 2.64% |
| 2021 | 60.59 Billion INR | 1.6% |
| 2020 | 59.63 Billion INR | -33.56% |
| 2019 | 89.76 Billion INR | -0.23% |
| 2018 | 89.97 Billion INR | 21.18% |
| 2017 | 74.24 Billion INR | 28.78% |
| 2016 | 57.65 Billion INR | 1.14% |
| 2015 | 57 Billion INR | -1.31% |
| 2014 | 57.76 Billion INR | 0.95% |
| 2013 | 57.21 Billion INR | 11.25% |
| 2012 | 51.42 Billion INR | 19.52% |
| 2011 | 43.03 Billion INR | 25.33% |
| 2010 | 34.33 Billion INR | -9.2% |
| 2009 | 37.81 Billion INR | 7.48% |
| 2008 | 35.17 Billion INR | 41.35% |
| 2007 | 24.88 Billion INR | 37.53% |
| 2006 | 18.09 Billion INR | 20.22% |
| 2005 | 15.05 Billion INR | 28.63% |
| 2004 | 11.7 Billion INR | 36.2% |
| 2003 | 8.59 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 17.31 Billion INR | -1.53% |
| 2024 Q2 | 17.42 Billion INR | 1.19% |
| 2023 Q1 | 15.66 Billion INR | -5.68% |
| 2023 Q3 | 16.65 Billion INR | -0.09% |
| 2023 Q2 | 16.66 Billion INR | 6.4% |
| 2023 Q4 | 17.58 Billion INR | 5.61% |
| 2023 FY | 67.02 Billion INR | 7.78% |
| 2022 Q2 | 15.84 Billion INR | 10.02% |
| 2022 FY | 62.19 Billion INR | 2.64% |
| 2022 Q4 | 16.6 Billion INR | 8.33% |
| 2022 Q3 | 15.33 Billion INR | -3.25% |
| 2022 Q1 | 14.4 Billion INR | -4.88% |
| 2021 FY | 60.59 Billion INR | 1.6% |
| 2021 Q4 | 15.14 Billion INR | 16.71% |
| 2021 Q1 | 16.13 Billion INR | 3.98% |
| 2021 Q3 | 12.97 Billion INR | -20.57% |
| 2021 Q2 | 16.33 Billion INR | 1.25% |
| 2020 Q2 | 23.26 Billion INR | 26.07% |
| 2020 FY | 59.63 Billion INR | -33.56% |
| 2020 Q4 | 15.51 Billion INR | -11.01% |
| 2020 Q1 | 18.45 Billion INR | -20.03% |
| 2020 Q3 | 17.43 Billion INR | -25.05% |
| 2019 Q1 | 21.52 Billion INR | -8.48% |
| 2019 FY | 89.76 Billion INR | -0.23% |
| 2019 Q2 | 22.36 Billion INR | 3.89% |
| 2019 Q3 | 22.79 Billion INR | 1.94% |
| 2019 Q4 | 23.07 Billion INR | 1.2% |
| 2018 Q1 | 20.46 Billion INR | -7.98% |
| 2018 Q4 | 23.52 Billion INR | -0.04% |
| 2018 FY | 89.97 Billion INR | 21.18% |
| 2018 Q3 | 23.53 Billion INR | 4.79% |
| 2018 Q2 | 22.45 Billion INR | 9.74% |
| 2017 Q1 | 15.56 Billion INR | -2.68% |
| 2017 FY | 74.24 Billion INR | 28.78% |
| 2017 Q4 | 22.23 Billion INR | 7.54% |
| 2017 Q3 | 20.67 Billion INR | 25.94% |
| 2017 Q2 | 16.41 Billion INR | 5.5% |
| 2016 Q3 | 14.38 Billion INR | 5.82% |
| 2016 Q4 | 15.99 Billion INR | 11.14% |
| 2016 Q2 | 13.59 Billion INR | -2.95% |
| 2016 FY | 57.65 Billion INR | 1.14% |
| 2016 Q1 | 14 Billion INR | -5.65% |
| 2015 FY | 57 Billion INR | -1.31% |
| 2015 Q1 | 14.38 Billion INR | -5.57% |
| 2015 Q2 | 14.44 Billion INR | 0.44% |
| 2015 Q3 | 13.37 Billion INR | -7.45% |
| 2015 Q4 | 14.84 Billion INR | 11.05% |
| 2014 Q3 | 14.3 Billion INR | 5.0% |
| 2014 Q4 | 15.23 Billion INR | 6.5% |
| 2014 Q2 | 13.62 Billion INR | -6.74% |
| 2014 FY | 57.76 Billion INR | 0.95% |
| 2014 Q1 | 14.6 Billion INR | -5.87% |
| 2013 FY | 57.21 Billion INR | 11.25% |
| 2013 Q4 | 15.51 Billion INR | 8.68% |
| 2013 Q3 | 14.27 Billion INR | 0.24% |
| 2013 Q2 | 14.24 Billion INR | 188.89% |
| 2013 Q1 | 4.93 Billion INR | -64.49% |
| 2012 Q3 | 13.01 Billion INR | 7.62% |
| 2012 FY | 51.42 Billion INR | 19.52% |
| 2012 Q4 | 13.88 Billion INR | 6.64% |
| 2012 Q2 | 12.09 Billion INR | 177.6% |
| 2012 Q1 | 4.35 Billion INR | -64.29% |
| 2011 FY | 43.03 Billion INR | 25.33% |
| 2011 Q3 | 10.9 Billion INR | 0.0% |
| 2011 Q4 | 12.2 Billion INR | 11.9% |
| 2010 FY | 34.33 Billion INR | -9.2% |
| 2009 FY | 37.81 Billion INR | 7.48% |
| 2008 FY | 35.17 Billion INR | 41.35% |
| 2007 FY | 24.88 Billion INR | 37.53% |
| 2006 FY | 18.09 Billion INR | 20.22% |
| 2005 FY | 15.05 Billion INR | 28.63% |
| 2004 FY | 11.7 Billion INR | 36.2% |
| 2003 FY | 8.59 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 4.21 Billion INR | -1491.267% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -16642.475% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -299.748% |
| FDC Limited | 19.42 Billion INR | -244.987% |
| Gufic Biosciences Limited | 8.06 Billion INR | -730.939% |
| Hikal Limited | 17.84 Billion INR | -275.597% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -423.296% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -214.278% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -4242.03% |
| Medico Remedies Limited | 1.44 Billion INR | -4525.219% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -297.9% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -6908.44% |
| RPG Life Sciences Limited | 5.82 Billion INR | -1051.602% |
| Sequent Scientific Limited | 13.69 Billion INR | -389.359% |
| Shilpa Medicare Limited | 11.53 Billion INR | -481.291% |
| Sigachi Industries Limited | 3.98 Billion INR | -1580.11% |
| Themis Medicare Limited | 3.81 Billion INR | -1655.785% |
| Unichem Laboratories Limited | 16.57 Billion INR | -304.419% |
| Venus Remedies Limited | 5.91 Billion INR | -1033.3% |
| Wanbury Limited | 5.75 Billion INR | -1064.406% |
| ZIM Laboratories Limited | 3.67 Billion INR | -1723.834% |
| Lupin Limited | 196.56 Billion INR | 65.9% |
| Innova Captab Limited | 10.81 Billion INR | -519.89% |
| Ind-Swift Limited | 5.02 Billion INR | -1233.995% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -1315.853% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 76.888% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -441.259% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -417.387% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -1724.645% |
| Morepen Laboratories Limited | 17.01 Billion INR | -293.848% |
| Laurus Labs Limited | 50.01 Billion INR | -34.01% |
| Aarti Drugs Limited | 25.28 Billion INR | -165.086% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -193.573% |
| Alembic Limited | 1.57 Billion INR | -4156.207% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -9.666% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 43.259% |
| Vaishali Pharma Limited | 862.79 Million INR | -7668.803% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -269.203% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -3111.709% |
| Eris Lifesciences Limited | 20.09 Billion INR | -233.62% |
| Windlas Biotech Limited | 6.3 Billion INR | -962.34% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 86.179% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -1054.578% |
| Orchid Pharma Limited | 8.19 Billion INR | -718.057% |
| Albert David Limited | 3.62 Billion INR | -1749.271% |
| Hester Biosciences Limited | 3.04 Billion INR | -2100.948% |
| Sakar Healthcare Limited | 1.54 Billion INR | -4247.809% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -537.549% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -482.223% |
| Divi's Laboratories Limited | 78.45 Billion INR | 14.558% |
| Mankind Pharma Limited | 103.34 Billion INR | 35.142% |
| Neuland Laboratories Limited | 15.58 Billion INR | -330.064% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -94.418% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 64.761% |
| Wockhardt Limited | 27.89 Billion INR | -140.333% |
| Bal Pharma Limited | 3.39 Billion INR | -1875.977% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 75.989% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -770.23% |
| Alkem Laboratories Limited | 126.67 Billion INR | 47.086% |
| Valiant Laboratories Limited | 1.82 Billion INR | -3581.755% |
| Ajanta Pharma Limited | 42.08 Billion INR | -59.263% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -4296.333% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -1594.286% |
| Granules India Limited | 45.06 Billion INR | -48.743% |
| Medicamen Biotech Limited | 1.79 Billion INR | -3638.242% |
| Ipca Laboratories Limited | 77.05 Billion INR | 13.016% |
| Brooks Laboratories Limited | 794.86 Million INR | -8332.795% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -2485.556% |
| Piramal Enterprises Limited | 60.33 Billion INR | -11.09% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 36.797% |
| NATCO Pharma Limited | 40.02 Billion INR | -67.489% |
| Suven Life Sciences Limited | 116.92 Million INR | -57224.53% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -13193.734% |
| Strides Pharma Science Limited | 40.51 Billion INR | -65.458% |
| Indoco Remedies Limited | 18.17 Billion INR | -268.84% |
| Alpa Laboratories Limited | 1.08 Billion INR | -6064.21% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -6324.402% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -8772.69% |